Cargando…

Detection of inhibitors of Candida albicans Cdr transporters using a diS-C(3)(3) fluorescence

Candida albicans is a major cause of opportunistic and life-threatening, systemic fungal infections. Hence new antifungal agents, as well as new methods to treat fungal infections, are still needed. The application of inhibitors of drug-efflux pumps may increase the susceptibility of C. albicans to...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczepaniak, Joanna, Łukaszewicz, Marcin, Krasowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353304/
https://www.ncbi.nlm.nih.gov/pubmed/25806026
http://dx.doi.org/10.3389/fmicb.2015.00176
Descripción
Sumario:Candida albicans is a major cause of opportunistic and life-threatening, systemic fungal infections. Hence new antifungal agents, as well as new methods to treat fungal infections, are still needed. The application of inhibitors of drug-efflux pumps may increase the susceptibility of C. albicans to drugs. We developed a new fluorescence method that allows the in vivo activity evaluation of compounds inhibiting of C. albicans transporters. We show that the potentiometric dye 3,3′-dipropylthiacarbocyanine iodide diS-C(3)(3) is pumped out by both Cdr1 and Cdr2 transporters. The fluorescence labeling with diS-C(3)(3) enables a real-time observation of the activity of C. albicans Cdr1 and Cdr2 transporters. We demonstrate that enniatin A and beauvericin show different specificities toward these transporters. Enniatin A inhibits diS-C(3)(3) efflux by Cdr1 while beauvericin inhibits both Cdr1p and Cdr2p.